Walleye Capital LLC Decreases Stake in Modular Medical, Inc. $MODD

Walleye Capital LLC lowered its position in Modular Medical, Inc. (NASDAQ:MODD) by 35.7% in the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 26,403 shares of the company’s stock after selling 14,647 shares during the quarter. Walleye Capital LLC owned about 0.06% of Modular Medical worth $29,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in MODD. AWM Investment Company Inc. increased its holdings in Modular Medical by 22.2% in the 4th quarter. AWM Investment Company Inc. now owns 916,666 shares of the company’s stock worth $1,256,000 after acquiring an additional 166,666 shares during the last quarter. Wealthedge Investment Advisors LLC increased its holdings in Modular Medical by 261.6% in the 1st quarter. Wealthedge Investment Advisors LLC now owns 137,569 shares of the company’s stock worth $150,000 after acquiring an additional 99,524 shares during the last quarter. Citadel Advisors LLC purchased a new stake in Modular Medical in the 4th quarter worth about $88,000. Finally, Chicago Partners Investment Group LLC purchased a new stake in Modular Medical in the 1st quarter worth about $38,000. Hedge funds and other institutional investors own 27.47% of the company’s stock.

Modular Medical Stock Performance

Shares of MODD opened at $0.72 on Friday. The firm has a market cap of $39.59 million, a P/E ratio of -1.40 and a beta of 0.17. Modular Medical, Inc. has a fifty-two week low of $0.63 and a fifty-two week high of $2.50. The business has a 50-day moving average of $0.72 and a 200 day moving average of $0.84.

Modular Medical (NASDAQ:MODD) last announced its quarterly earnings results on Thursday, August 14th. The company reported ($0.12) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.02).

Modular Medical Profile

Modular Medical, Inc operates as a medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. The company is headquartered in San Diego, California.